Allulose Mimics GLP-1 Hormones to Reduce Cravings and Balance Blood Sugar

5Mind. The Meme Platform

This rare sugar may support satiety, blunt blood sugar spikes, and fit seamlessly into everyday meals.

Donna began using allulose anywhere she’d once used sugar, including treats like brownies and pumpkin muffins. Looking back, she says finding allulose was key.

“It’s the main thing I’ve done differently compared to other low-carb diets.”

Semaglutide and other new GLP-1 medications have dominated the weight loss industry, offering appetite suppression and improved blood sugar control. At roughly $1,000 per month before insurance, they are beyond reach for many people. For others, it’s the side effects of these drugs that have them searching for natural alternatives.

Enter allulose—a zero-calorie, rare sugar that stimulates the same GLP-1 hormone, though to a more modest extent than the drugs, and provides mild metabolic benefits.

How Allulose Is More Than a Sweetener

Allulose is a naturally occurring sugar found in small amounts in foods like figs, raisins, and maple syrup. Unlike regular sugar, allulose is absorbed in the bloodstream but not fully metabolized into energy—about 90 percent is excreted in urine—so it provides almost no calories or usable energy. Research shows that this unique metabolic fate, which avoids spiking blood sugar or insulin levels, sets allulose apart from table sugar. Allulose also has a unique metabolic profile among low-calorie sweeteners.

Allulose and GLP-1 Stimulation for Satiety 

GLP-1 is a hormone released by the gut in response to food intake. It promotes satiety—the feeling of fullness after meals— slows gastric emptying, and enhances insulin secretion. Together, these effects help people lose weight on the GLP-1 agonist drugs.

In a 2022 randomized controlled study, healthy adults given allulose experienced a significant increase in GLP-1 and other gut hormones like cholecystokinin and peptide YY, compared with tap water. This hormonal response is associated with signals that promote fullness, although the effect on subjective appetite was less pronounced for allulose than for some other sweeteners like erythritol.

The same study noted that the mechanism by which allulose triggers GLP-1 release appears to be independent of the gut’s sweet taste receptor (T1R2/T1R3), suggesting it acts through a different pathway than glucose or artificial sweeteners. This unique action could make allulose a valuable tool for metabolic health.

Blood Sugar Control and Fat Metabolism

Allulose’s benefits extend beyond hormone stimulation. A 2023 meta-analysis found that consuming just 5 grams of allulose with a carbohydrate-containing meal significantly reduced post-meal blood glucose spikes in healthy adults.

“D-Allulose is a valuable blood glucose management tool for healthy humans and diabetes patients. Allulose Diet enables reduction of sucrose intake through Sugar Reformulation in the future diet,” the authors wrote.

The effect was robust across multiple studies, with both 5-gram and 10-gram doses showing a meaningful reduction after eating, suggesting that allulose may help blunt the rapid rise in blood sugar that typically follows high-carb meals—a key factor in preventing diabetes and supporting weight management.

Animal and preliminary human studies also hint at allulose’s potential to reduce fat accumulation and preserve muscle glycogen during exercise—though more research is needed to confirm these effects in large-scale human trials.

Glycogen is a complex carbohydrate molecule stored in muscles and the liver that serves as a source of energy, especially during exercise.

How to Use Allulose and What to Avoid

Allulose may be worth experimenting with for people looking to transition off GLP-1 medications and avoid common rebound weight gain, or for those who want to reduce post-meal glucose spikes or maintain metabolic flexibility without giving up sweet foods. Based on the human studies and clinical experience, timing and dose matter significantly, as some people may experience mild discomfort.

By Sheridan Genrich

Read Full Article on TheEpochTimes.com

Contact Your Elected Officials
The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

After October 7th, Deterrence Is No Longer Enough

Israel has begun to shift from deterrence to denial. Deterrence seeks to influence an adversary’s behavior by raising the cost of action.

What’s At Stake In The “Battle For Hungary”?

Sunday’s parliamentary elections in Hungary have been described by...

Our Water is Polluted!   

Sometimes a writer has to have a story percolate...

Think America Is So Bad? Think Again.

There seems to be a growing sentiment, especially among younger Americans, that the United States is some kind of terrible place to live.

People are Waking Up to Islam   

President Donald Trump is not the only one waking...

Artemis II Mission Ends With Splashdown Off San Diego

Artemis II, NASA’s 10-day test flight around the moon concluded on April 10 when the Orion spacecraft parachuted into the Pacific Ocean off San Diego.

Hunter Biden Challenges Trump Brothers to Cage Match

The son of former President Biden says he is ‘100 percent in’ for a fight against Donald Trump Jr. and Eric Trump, arranged by influencer Andrew Callaghan.

CBP Reports 11 Consecutive Months of Zero Releases at the Border

There have been fewer than 9,000 apprehensions at the...

FDA Withdraws Approval of Drug Promoted as Autism Treatment

Generic versions of the drug will still be available,...

Trump Says Pam Bondi is Out as His Attorney General

President Trump says Pam Bondi is out as his Attorney General. Bondi will be replaced by her deputy Todd Blanche, who will serve as acting attorney general.

Trump Signs Order Imposing 100 Percent Tariffs on Certain Imported Pharmaceutical Drugs

President Donald Trump signed executive orders on Thursday raising levies on some medications and refining calculations on steel tariffs.

Trump Says US Core Objectives in Iran Are ‘Nearing Completion’ in Primetime Address

President Trump will deliver a primetime address from the White House on April 1 to update the nation on the U.S. military operation against Iran.
spot_img

Related Articles

Popular Categories

MAGA Business Central